873206-08-7Relevant academic research and scientific papers
Dirhodium(II)/Xantphos-Catalyzed Relay Carbene Insertion and Allylic Alkylation Process: Reaction Development and Mechanistic Insights
Liang, Xinyi,Lu, Bin,Peng, Qian,Wang, Xiaoming,Wang, Zijian,Zhang, Jinyu
, p. 11799 - 11810 (2021)
Although dirhodium-catalyzed multicomponent reactions of diazo compounds, nucleophiles and electrophiles have achieved great advance in organic synthesis, the introduction of allylic moiety as the third component via allylic metal intermediate remains a formidable challenge in this area. Herein, an attractive three-component reaction of readily accessible amines, diazo compounds, and allylic compounds enabled by a novel dirhodium(II)/Xantphos catalysis is disclosed, affording various architecturally complex and functionally diverse α-quaternary α-amino acid derivatives in good yields with high atom and step economy. Mechanistic studies indicate that the transformation is achieved through a relay dirhodium(II)-catalyzed carbene insertion and allylic alkylation process, in which the catalytic properties of dirhodium are effectively modified by the coordination with Xantphos, leading to good activity in the catalytic allylic alkylation process.
Bicyclic cyanothiazolidines as novel dipeptidyl peptidase 4 inhibitors
Betancort, Juan M.,Winn, David T.,Liu, Ruzhang,Xu, Quansheng,Liu, Junjuan,Liao, Wensheng,Chen, Shu-Hui,Carney, David,Hanway, Denise,Schmeits, James,Li, Xinqiang,Gordon, Eric,Campbell, David A.
scheme or table, p. 4437 - 4440 (2010/04/05)
The synthesis and biochemical evaluation of novel cyanothiazolidine inhibitors of dipeptidyl peptidase 4 (DPP4) is described. Their main structural feature is a constrained bicyclic core that prevents the intramolecular formation of inactive cyclic species. The inhibitors show good to moderate biochemical potency against DPP4 and display distinct selectivity profiles towards DPP7, DPP8 and DPP9 depending on their substitution.
Constrained cyano compounds
-
Page/Page column 22, (2010/02/15)
Certain constrained cyano compounds are useful as inhibitors of post-proline/alanine cleaving amino-dipeptidases. Accordingly, these compounds can be employed, alone or with another therapeutic agent, to treat diabetes (especially, Type II diabetes), hyperglycemia, Syndrome X, diabetic complications, hyperinsulinemia, obesity, atherosclerosis and related diseases, as well as various immunomodulatory diseases and chronic inflammatory bowel disease.
